Siemens Healthcare Diagnostics is recalling several Atellica CH reagents used in laboratory testing, affecting approximately 38,630 units worldwide. The recall includes specific reagents for LDL Cholesterol Direct (DLDL), Total Protein II (TP), and two types of Triglycerides (Trig and Trig_2). These reagents may carry over during the testing process on the Atellica CH Analyzer, which can interfere with and cause inaccurate results for magnesium (Mg) levels. Consumers should contact their healthcare provider or the manufacturer for further instructions.
The defect causes 'reagent carryover,' where chemical residue from one test contaminates the next, leading to potentially inaccurate magnesium measurements. Incorrect magnesium results can lead to a misdiagnosis or inappropriate treatment for patients with electrolyte imbalances.
Manufacturer mitigation and healthcare provider consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.